Achieve Life Sciences, Inc. (ACHV) News

Achieve Life Sciences, Inc. (ACHV): $4.31

0.01 (+0.23%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add ACHV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#233 of 332

in industry

Filter ACHV News Items

ACHV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ACHV News Highlights

  • For ACHV, its 30 day story count is now at 5.
  • Over the past 7 days, the trend for ACHV's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about ACHV are DEC, DRUG and PRE.

Latest ACHV News From Around the Web

Below are the latest news stories about ACHIEVE LIFE SCIENCES INC that investors may wish to consider to help them evaluate ACHV as an investment opportunity.

ACHV: Not So Fast…

By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT Update to the Timeline On December 11th, 2023, Achieve Life Sciences, Inc. (NASDAQ:ACHV) filed Form 8-K updating investors on its interactions with the FDA. The company held a pre-new drug application (NDA) meeting with the agency in October regarding cytisinicline, which was followed by additional interaction and written

Yahoo | December 18, 2023

Life Science Investor Forum: Presentations Now Available for Online Viewing

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Investor Forum sponsored by Zacks Small-Cap Research. held December 14th are now available for online viewing. REGISTER NOW AT: https://bit.ly/41oBqxg The company presentations will be available 24/7 for 90 days. Investors, adv

Yahoo | December 15, 2023

TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors

FORT WORTH, Texas, Dec. 13, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the appointment of Thomas B. King to its Board of Directors. “I am pleased to welcome Thomas King to our Board of Directors,” said Harlan Weisman, M.D., Vice Chairman and Chief Executive Officer of TFF Pharmaceu

Yahoo | December 13, 2023

LCID Stock Alert: Lucid Announces CFO Departure

Lucid stock is falling on Tuesday as investors in LCID react to the company's CFO departing immediately to pursue other opportunities.

William White on InvestorPlace | December 12, 2023

Why Is Achieve Life Sciences (ACHV) Stock Down 44% Today?

Achieve Life Sciences stock is falling on Tuesday after the company provided ACHV investors with an FDA update concerning an NDA.

William White on InvestorPlace | December 12, 2023

Wyndham Hotels (WH) Stock Pops on Takeover Offer

Wyndham Hotels stock is getting a boost on Tuesday following a takeover offer from Choice Hotels International for shares of WH.

William White on InvestorPlace | December 12, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

William White on InvestorPlace | December 12, 2023

Life Science Investor Forum Agenda Announced for December 14th, 2023

NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum to be held December 14th. This event is sponsored by Zacks Small-Cap Research. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/3tcvQkSIt is recommended that investors pre-register and run the online system check to expedite participat

Yahoo | December 12, 2023

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

SEATTLE and VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that Achieve management will be participating in the following upcoming investor conferences. John Bencich, CEO of Achieve, will be presenting and participating in a live panel at the Life Sciences Investor

Yahoo | December 11, 2023

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call Transcript November 9, 2023 Achieve Life Sciences, Inc. reports earnings inline with expectations. Reported EPS is $-0.34 EPS, expectations were $-0.34. Operator: Greetings. Welcome to Achieve Life Sciences Third Quarter Earnings Conference Call and Webcast. [Operator Instructions] Please note this conference is being recorded. At this […]

Yahoo | November 11, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!